MyFinsight
Home
Blog
About
Contact
Download
Download image
Revenues-Product
$51,663M
(-4.00%↓ Y/Y)
Alliance revenues
$9,266M
(10.47%↑ Y/Y)
Revenues-Royalty
$1,650M
(15.95%↑ Y/Y)
Total revenues
$62,579M
(-1.65%↓ Y/Y)
Income from continuing
operations before...
$7,520M
(-6.27%↓ Y/Y)
Provision/(benefit) for taxes on
income
-$266M
(-850.00%↓ Y/Y)
Cost of sales
$16,067M
(-9.99%↓ Y/Y)
Selling, informational
and administrative...
$13,794M
(-6.35%↓ Y/Y)
Research and development
expenses
$10,437M
(-3.56%↓ Y/Y)
Other
(income)/deductionsnet
-$6,724M
(-53.24%↓ Y/Y)
Amortization of intangible
assets
$4,874M
(-7.79%↓ Y/Y)
Acquired in-process
research and development...
$1,613M
(1393.52%↑ Y/Y)
Restructuring charges and
certain...
$1,550M
(-35.92%↓ Y/Y)
Income from continuing
operations
$7,787M
(-3.28%↓ Y/Y)
Discontinued operationsnet
of tax
$25M
(127.27%↑ Y/Y)
Net income before
allocation to...
$7,812M
(-3.10%↓ Y/Y)
Net income
attributable to pfizer inc....
$7,771M
(-3.24%↓ Y/Y)
Less net income
attributable to...
$41M
(32.26%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Pfizer_(2021)-svg
PFIZER INC (PFE)
Pfizer_(2021)-svg
PFIZER INC (PFE)